Free Trial

InnovAge (INNV) Stock Price, News & Analysis

InnovAge logo
$2.98 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$2.96 -0.02 (-0.50%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About InnovAge Stock (NASDAQ:INNV)

Key Stats

Today's Range
$2.95
$3.06
50-Day Range
$2.98
$3.95
52-Week Range
$2.94
$6.69
Volume
23,884 shs
Average Volume
51,548 shs
Market Capitalization
$403.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Reduce

Company Overview

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

Remove Ads

InnovAge Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
37th Percentile Overall Score

INNV MarketRank™: 

InnovAge scored higher than 37% of companies evaluated by MarketBeat, and ranked 756th out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    InnovAge has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    InnovAge has received no research coverage in the past 90 days.

  • Read more about InnovAge's stock forecast and price target.
  • Earnings Growth

    Earnings for InnovAge are expected to grow in the coming year, from ($0.12) to $0.06 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InnovAge is -15.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InnovAge is -15.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    InnovAge has a P/B Ratio of 1.57. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about InnovAge's valuation and earnings.
  • Percentage of Shares Shorted

    1.56% of the float of InnovAge has been sold short.
  • Short Interest Ratio / Days to Cover

    InnovAge has a short interest ratio ("days to cover") of 4.5.
  • Change versus previous month

    Short interest in InnovAge has recently decreased by 11.45%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    InnovAge does not currently pay a dividend.

  • Dividend Growth

    InnovAge does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.56% of the float of InnovAge has been sold short.
  • Short Interest Ratio / Days to Cover

    InnovAge has a short interest ratio ("days to cover") of 4.5.
  • Change versus previous month

    Short interest in InnovAge has recently decreased by 11.45%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    InnovAge has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.
  • Insider Buying vs. Insider Selling

    In the past three months, InnovAge insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.40% of the stock of InnovAge is held by insiders.

  • Percentage Held by Institutions

    Only 12.26% of the stock of InnovAge is held by institutions.

  • Read more about InnovAge's insider trading history.
Receive INNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter.

INNV Stock News Headlines

New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
See More Headlines

INNV Stock Analysis - Frequently Asked Questions

InnovAge's stock was trading at $3.93 at the start of the year. Since then, INNV shares have decreased by 24.2% and is now trading at $2.98.
View the best growth stocks for 2025 here
.

InnovAge Holding Corp. (NASDAQ:INNV) announced its earnings results on Tuesday, February, 4th. The company reported ($0.10) EPS for the quarter. InnovAge had a negative net margin of 3.19% and a negative trailing twelve-month return on equity of 9.45%.

InnovAge (INNV) raised $301 million in an IPO on Thursday, March 4th 2021. The company issued 16,700,000 shares at $17.00-$19.00 per share. J.P. Morgan, Barclays, Goldman Sachs and Citigroup acted as the underwriters for the IPO and Baird, William Blair, Piper Sandler, Capital One Securities, Loop Capital Markets, Siebert Williams Shank and Roberts & Ryan were co-managers.

Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that InnovAge investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), NVIDIA (NVDA), Meta Platforms (META), Netflix (NFLX) and Home Depot (HD).

Company Calendar

Last Earnings
2/04/2025
Today
4/01/2025
Next Earnings (Estimated)
5/06/2025
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Health services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:INNV
Fax
N/A
Employees
2,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.00
High Stock Price Target
$5.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+62.9%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-21,340,000.00
Pretax Margin
-3.24%

Debt

Sales & Book Value

Annual Sales
$806.61 million
Price / Cash Flow
N/A
Book Value
$1.90 per share
Price / Book
1.62

Miscellaneous

Free Float
133,351,000
Market Cap
$415.20 million
Optionable
Optionable
Beta
0.39
7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:INNV) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners